Slides:



Advertisements
Similar presentations
Predictors of Change in HIV Risk Factors for Adolescents Admitted to Substance Abuse Treatment Passetti, L. L., Garner, B. R., Funk, R., Godley, S. H.,
Advertisements

Drug and Alcohol Treatment Outcomes in Older Adults Derek D. Satre, Ph.D. Jennifer Mertens, M.A. Sujaya Parthasarathy, Ph.D. Constance Weisner, Dr.PH.,
Increases in Oral and Anal Sexual Exposure among Adolescents Attending STD Clinics in Baltimore Renee M Gindi, MPH, Khalil G Ghanem MD, Emily J Erbelding,
Dr. Elaine Dunnea, Dr. Maura Dugganb, Dr. Julie O’Mahonyc
TMC125 Safety and Tolerability: 24-week Results of the Pooled DUET-1 and -2 Trials R Haubrich, M Schechter, S Walmsley, M Peeters, M Janssens, G De Smedt.
Marijuana and Teenage Psychosis David Ruffino Student Nurse. PPC Term Five.
Journal Club Alcohol and Health: Current Evidence November–December 2004.
Mental Health from a Public Health Perspective Professor Carol S. Aneshensel Department of Community Health Sciences 10/12/09.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September-October 2007.
Consumer Health Mental Health Care. Extent of mental health needs Practitioners Types therapy Selecting a therapist Hospital care Questionable “self-help”
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2010.
SCHIZOPHRENIA DISABILITIES POOR SOCIAL, FAMILY, AND WORK RELATIONSHIPS SIDE EFFECTS OF MEDICATION VIOLENCE WHEN IN PSYCHOTIC STATE SOCIAL STIGMA.
Are Benzodiazepines Still the Medication of Choice for Patients With Panic Disorder With or Without Agoraphobia? By : s.bruce, PhD et al (Am J Psychiatry.
IS CANNABIS A RISK FACTOR FOR SCHIZOPHRENIA? Jouko Miettunen Department of Public Health and Primary Care Institute of Public Health University of Cambridge.
The Changing Role of Medication in Advancing Recovery NYAPRS Conference.
Prognostic Factors in Child and Adolescent Psychiatry. A. James Oxford University.
Jouko Miettunen University of Oulu, Finland
Wei Hao, MD. Mental Health Institute WHO Collaborating Center for Drug Abuse and Health Central South University Prevalence Rates and Related Factors of.
Meredith Bailey, LCSW Timberlawn Hospital February 26,
The Lowdown on High Doses: Opioid Medications for Chronic Low Back Pain This analysis is based on information from the 137 subjects who responded to the.
Mood Disorders. Major Depressive Disorder  Five or more symptoms present for two weeks or more:  Disturbed Mood  depressed mood  anhedonia (reduced.
Characteristics of Patients Using Extreme Opioid Dosages in the Treatment of Chronic Low Back Pain In this sample of 204 participants, 70% were female,
Initial presentation of multiple sclerosis in northern Iran; Is there any comparison to other countries Initial presentation of multiple sclerosis in northern.
THE IMPACT OF MARIJUANA ON HEALTH AND HEALTHCARE Ewald Horwath, MD, MS, FAPA Professor and Chair, Department of Psychiatry Associate Clinical Director,
MADELYN CABRERA, PSY.D. JESUS PEREZ, PSY.D. CITRUS HEALTH NETWORK, INC HIALEAH, FL Patient Diagnostic Differences and Demographics at an Adult Crisis Stabilization.
Marijuana and Psychosis Prepared by Dr Amir Barsoum, MD, FRCPC Home on the Hill Lecture Series Sept 16, 2015.
Introduction The Relationship between Neurocognitive Functioning and Childhood Abuse among Persons with SMI: Mediating Proximal and Distal Factors L. Felice.
Barbara Pajk, M.N. University Psychiatric Clinic Ljubljana Barcelona,
Schizophrenia Chapter 14. Louis Wain cat This cat, like many painted during that period, is shown with abstract patterns behind it. Psychologists have.
1 IRIS Initiative to Reduce the Impact of Schizophrenia DON’T DELAY! IT’S TIME TO REDUCE THE IMPACT OF PSYCHOSIS IN YOUNG PEOPLE……. NOW!
Understanding Cognitive Disability in Schizophrenia Cameron S. Carter MD University of California at Davis.
Smoking and Mental Health Problems in Treatment-Seeking University Students Eric Heiligenstein, M.D. University of Wisconsin-Madison Health Services Stevens.
Brain diseases: Substance abuse and co-occurring disorders Mark Publicker, MD FASAM.
Virtual ACE Update.
1 SSC 2006: Case Study #2: Obstructive Sleep Apnea Rachel Chu, Shuyu Fan, Kimberly Fernandes, and Jesse Raffa Department of Statistics, University of British.
Selected Effects on Brain, Body
Elevated Reports of Anxiety Symptoms among Pediatric Chronic Pain Patients: A Need for Routine Screening? Susan T. Heinze¹, B.A., Kim Anderson Khan², ³,
DRD2 Gene in Alcohol Dependence 국립중앙의료원 이 소 희. Background Dopamine – Reward behavior (Wise & Rompre, 1989) – Alcoholism Mesolimbic dopamine system – 5.
PHQ-9 Severity and Screening Tests Predictive of Remission Outcomes at Six Months Kurt B. Angstman, MS MD Associate Professor John M. Wilkinson Assistant.
BASELINE BMI DOES NOT PREDICT SIX MONTH REMISSION RATE FOR DEPRESSION MANAGED UNDER COLLABORATIVE CARE MANAGEMENT Kurt B. Angstman, MS MD Todd W. Wade,
Neurologic Effects Associated With Efavirenz Generally Mild, Transient Slideset on: Clifford DB, Evans S, Yang Y, et al. Impact of efavirenz on neuropsychological.
Efavirenz Use Not Associated With Depressive Episodes, According to Analysis of Randomized Clinical Trial Outcomes Slideset on: Journot V, Chene G, De.
PSYCHOTIC DISORDER Mental Health First Aid By Mental Health Commission of Canada, 2010.
ANCO 2006 ASH UPDATE MDS Joseph M. Tuscano, M.D. UC Davis Cancer Center.
©2016 MFMER | slide-1 Patient screening tools associated with prediction of depression remission at six months Kurt B. Angstman, MS MD Professor of Family.
Introduction  Schizophrenia ↓ Neuro-developmental Disorder ↕ Pathogenesis in gestation and early childhood ↕ Further research is needed.
©2015 MFMER | slide-1 PTSD: Worsening outcomes for comorbid depression… even with collaborative care management. Kurt B. Angstman, MS, MD Professor of.
Date of download: 9/20/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of a Palliative Care Intervention on Clinical.
Assistant Professor of Family Medicine
Generalized Logit Model
Impact of Sleep Disturbances on Post-Traumatic Stress Disorder Symptoms and Perceived Health Geneviève Belleville1,2, Stéphane Guay2, & André Marchand1,2.
Why anxiety associates with non-completion of pulmonary rehabilitation program in patients with COPD? Dr Abebaw Mengistu Yohannes Associate Professor.
Raafat R. Abdel-Malek, MD, FRCR Ass. Prof Clinical Oncology
Poorer Outcomes With Rituximab + Chemo in Heavier Patients, Older Men With Follicular Lymphoma CCO Independent Conference Highlights of the 2015 ASCO Annual.
Stacy Coates Hodgkinson, MA Kennedy Krieger Institute
Weighing the Evidence: A Systematic Review on Long-Term Neurocognitive Effects of Cannabis Use in Abstinent Adolescents and Adults Authors: Florian Ganzer,
The Relationship Between Mental and Physical Health
Adam Thao & Stephanie Barajas California State University, Chico
Changes in the serum metabolites of tryptophan in abstinent cocaine and alcohol users and their relationship with co-morbid disorders October 24, 2017.
PREMIER: Rate of hypertension at 18 months
2University of Virginia
Cannabinoid Hyperemesis: A Case Series of 98 Patients
Adult Primary Immune Deficiency: What Are We Missing?
A.S.David, R.McCormack and Lishman Unit MDT
The Changing Role of Medication
Stacy D. Sanford, PhD, Jennifer L
Psychological Support for Kleine-Levin Syndrome
Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.
Overview of Secondary Outcome Domains
Understanding Depression
Presentation transcript:

 Marijuana use in adolescence and adulthood  Risk factor for schizophrenia  Worse outcomes  frequent and longer periods of hospitalization  higher relapse rates even in first-episode patients  elevated rates of extrapyramidal motor symptoms (EPS),  lower medication compliance  higher rates of unemployment, violence,  higher rate of criminality  increased risk of suicide Side effects of heavy marijuana use Barnett et al Verdoux and Tournier 2004 Stefanis et al. 2004

 Patients with cannabis abuse/dependence  smaller fronto-temporal WM volumes  Significant CNR1 (rs ) genotype-by- marijuana-use  effects on WM volumes  neurocognitive impairment Side effects of heavy marijuana use Agarwal et al,2009

Marijuana use in CVS  > 40% of adult CVS patients use marijuana  More likely to be male and young

CVS ( n=82)Functional vomiting (n=62) Odds ratio for CVS( 95% CI) P value Age (mean±SD) 30±1136±130.7( )0.005 Gender Female ( n=71) Male (n=73) 33 (40%) 49 (60%) 38 (61%) 24 (39%) 0.4(.2-0.9)0.02 Cannabis use30 (37%)8 (13%)2.9( )0.02 Retching55 (67%)25 (40%)4.4(2-9.7) Depression2 (2%)4 (6%)0.4( )0.35 Anxiety1 (1%)2 (3%)0.3( )0.41 Other psychiatric disorders 11 (13%)21 (34%)0.3( )0.006 Marijuana use in CVS Choung R.S.et al, Neurogastroenterology and Motility, 2012

 Retrospective chart reviews  Review of 31 published case reports  Case series of 98 patients  Association with chronic, daily marijuana use  Long duration of use preceding onset of symptoms (2-10 years)  Duration of follow up ( variable) Cannabinoid hyperemesis syndrome Wallace E.A. et al, S Med Journal, 2011 Simonetto DA et al, Mayo Clinic Proceedings, 2012

 Total of 437 patients with CVS  Mean age was 34 ± 12  Mostly Caucasian (92%)  Eighty-one % of patients reported use of marijuana to treat their symptoms  Marijuana users were more likely to be male and have associated anxiety An Internet survey of marijuana use in CVS Experimental Brain research,2014

This patient like several CVS patients took hot showers that soothed her Janet Leigh in “Psycho”

Self reported effects of marijuana in patients with CVS Venkatesan et al, International Conference of Nausea & Vomiting,Pittsburgh,2013

Hypothesis The activity of the endocannabinoid system (ECS) is significantly altered with an associated increase in salivary cortisol and alpha amylase.

CVS patients n=22 Controls n=12 P value Age40±1137±12NS Gender Female Male 17 (77%) 5 (23%) 10 (83%) 2 (17%) NS BMI NS Marijuana use8 (40%)0 (0%)0.002 * Pittsburgh Sleep Quality Index (PSQI) scores 12 ± 16 ± * Anxiety10 ± 15 ± * Depression7 ± ± * Baseline characteristics

Serum 2-AG and NAE concentrations in CVS patients and controls Data were analyzed using one way ANOVA and comparisons between groups were carried out using Bonferroni’s t-tests. * p<0.05; **p<0.01. Data analyzed using one way ANOVA,comparisons between groups were carried out using Bonferroni’s t-tests. * p<0.05; **p<0.01. Venkatesan et al,DDW2013

Variable Patients – well phase Patients - sick phase Controls P value (Sick vs well phase in patients) Salivary cortisol (s cort) 6.7 ( )16 ( ) 10.5 ( ) 0.09 Salivary alpha amylase 214 ( ) 285 ( ) 138 ( ) NS Salivary cortisol (nmol/L; median [range]), and salivary alpha amylase (U/ml; median [range]) in the well phase and during an episode in CVS patients and controls Venkatesan et al,DDW2013

Future direction

 Novel therapy  New drugs-manipulation of the ECS and HPA axis Future direction

Thank you Kathleen Adams & Mollie Sharon Coffie with GI nurses B Li Regal team of royal retchers! Cecilia Hillard Hershel Raff Reza Shaker Megan Yelena Melanie Shanika Cindy Sam